🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Dr. Nancy Speck, whose research has provided critical knowledge to help us understand how certain blood cancers and other blood disorders develop. Learn more about her work: pennmedicine.org/news/nancy-spe…

Penn has received two 2025 Hospital and Health System Association of Pennsylvania Achievement Awards. An initiative that expanded the hours of the Oncology Evaluation Center at Penn Medicine - Abramson Cancer Center has received the Optimal Operations Award. spr.ly/60194w4QT

At #ASCO25, Penn Medicine - Abramson Cancer Center's Vivek Narayan, MD, presented the five-year follow-up analysis from the phase III LITESPARK-004 trial of belzutifan, the first FDA-approved treatment for von Hippel-Lindau disease–related cancers. UroToday.com spr.ly/60144by0Q

A new study led by Eva Berlin, MD, provides reassurance that modern #BreastCancer #Radiotherapy does not show any clinically overt signs of effect to systolic function of the heart, likely due to low heart dose. The ASCO Post spr.ly/60114gpNx

Antibody-drug conjugates can cause distinct side effects. Corrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discussed practical strategies for how pharmacists can help identify and mitigate these potential toxicities. Pharmacy Times spr.ly/60124eEk0

A trial presented at #ASCO25 showed progress in treating metastatic HR-positive #BreastCancer w/ a combo therapy, though Amy Clark, MD, who was not involved in the study, noted there were important limitations of the study design to consider. MedPage Today spr.ly/60184gwK8

.Charu Aggarwal, MD, MPH, FASCO gave her perspective on an #ASCO25 study that can help identify high-risk patients w/ early-stage #NSCLC who would benefit from adjuvant chemotherapy. The findings will help “lay the foundation for precision therapy," she said. Healio spr.ly/60184irNm

.CBS Sunday Morning 🌞 took a look at cancer research funding, speaking with U.S. experts & patients about the impact of funding cuts. “Everyone concerned about funding for cancer research should watch this important piece,” said our own Dr. Robert Vonderheide. spr.ly/60144cp6m

Lack of access to healthy food is a threat to the lives of cancer survivors, according to new Penn Medicine research. The study reported that those experiencing #FoodInsecurity had a 28% relative increase in risk of death vs. those who were food secure. spr.ly/60184cTjI

Our own Anish Butala, MD, recently joined GeriPal - A Geriatrics & Palliative Care Podcast to explain what health care providers need to know about palliative radiation therapy. spr.ly/60174qaEN

A major thank you to the Penn Medicine faculty and staff across the health system who helped celebrate National Cancer Survivors Month in June! Penn Medicine Lancaster General Health Penn Medicine Princeton Health

Neoadjuvant #pembrolizumab showed both efficacy & safety among patients with stage IIB/IIC #melanoma without risking increased sentinel lymph node metastasis in a recent trial. Giorgos Karakousis, MD, presented the findings at #ASCO25. Oncology Learning Network spr.ly/60154sSAx

#ASCO25 research discussed investigational treatments for #lymphoma, including a revised staging system for natural killer T-cell lymphoma. The system “will allow for better prognostication & therapy intensification,” per Sunita Nasta, MD. CancerTherapyAdvisor spr.ly/60164QJ9e

.AbbVie recently announced that it would acquire Capstan Therapeutics, a Penn Medicine startup developing CAR T cell therapies for autoimmune conditions, fibrosis, and cancer. The Philadelphia Inquirer spr.ly/60174Qbsl

.Penn Medicine's latest set of wheels drives like a typical vehicle. However, step inside it and you'll find a clinic on wheels. The colorful, air-conditioned van houses advanced 3D mammography equipment for free breast cancer screenings. The Philadelphia Inquirer spr.ly/60164NN3E

In a Science Immunology study, researchers from Penn Vet, Penn Medicine, & Children's Hospital showed that modifying mRNA vaccines with a cytokine could make the benefits of vaccines last longer and offer a potential approach for reducing cancer risk. Genetic Engineering & Biotechnology News spr.ly/601844nUs

Mallorie Jones, a project manager on Penn Medicine - Abramson Cancer Center's Community Outreach and Engagement team is a semifinalist for the 2025 Be Well Philly Health Hero Challenge! Jones' work helped screen more than 1,000 #Philly men for prostate cancer. Cast your vote: spr.ly/60124Aia6

.Penn Medicine's Adeiyewunmi (Ade) Osinubi, MD, an Emergency Medicine resident working in the ABC News Medical Unit, details projections about the rising toll of #UterineCancer in the United States, especially for Black women. Adeiyewunmi (Ade) Osinubi, MD spr.ly/601944kj3